Pentobarbital

Sedation, anesthesia induction, and refractory status epilepticus management have historically utilized pentobarbital, a Schedule II short-acting barbiturate. Laboratory testing applications include drugs of abuse screening, forensic toxicology investigations of suspected barbiturate overdose or drug-facilitated crimes, postmortem toxicology, veterinary toxicology where pentobarbital is used for euthanasia, and clinical toxicology assessments in emergency departments evaluating sedative-hypnotic toxicity. UTAK’s single-analyte pentobarbital product, Barbiturates Panel, and DAU panels contain pentobarbital in lyophilized serum and urine matrices at multiple concentration levels, supporting both immunoassay screening and confirmation methods. Stock and custom QC solutions can incorporate related barbiturates such as phenobarbital, secobarbital, amobarbital, butalbital, and other commonly monitored sedative-hypnotics to address your laboratory’s comprehensive barbiturate and drugs of abuse testing requirements.